Phenotypic and Genotypic Characterization of Clinical Isolates Belonging to the (ACB) Complex Isolated From Animals Treated at a Veterinary Hospital in Switzerland.

We investigated a collection of strains belonging to the - (ACB) complex obtained from a veterinary clinic with regard to their genetic relatedness, presence of antibiotic resistance genes and antimicrobial susceptibility profiles. Fifty-eight ACB-complex strains from animals treated at a veterinary clinic between 2006 and 2017, and seven strains collected from the hospital environment during 2012 were analyzed. Assignment to sequence types (ST) and international complexes (IC) was done by multilocus sequence typing (MLST) according to the Pasteur scheme. Genes encoding carbapenemases, aminoglycoside-modifying enzymes, macrolide-, quinolone- and co-trimoxazole resistance genes, the IS element, virulence associated genes and plasmid associated toxin-antitoxin markers were identified by microarray. Genes encoding -like carbapenemases were amplified by PCR and sequenced. Susceptibility profiles were determined by disc diffusion or by broth microdilution. Among 50 isolates from animals, two predominant clones were observed linked to CC1 ( = 27/54% of the isolates) and CC25 ( = 14/28%), respectively. Strains of IC I harbored , ', and genes. Isolates belonging to CC25 possessed . Six (12%) isolates belonging to CC2 and carrying were also noted. One isolate belonged to CC10 ( ), one to CC149 ( ), the remaining isolate was assigned to ST1220 and possessed . Of six environmental , four (66.7%) belonged to CC25 ( ), one (16.7%) to CC2 ( ) and one to CC3 ( ). Nine isolates (eight from animals and one environmental strain) were non- strains and did not harbor -like genes. None of the isolates carried , , or , and none were resistant to carbapenems. Clonal lineages of the veterinary isolates in our collection are identical to those globally emerging in humans but do not harbor . CC25 may be specific for this particular veterinary clinic environment.